Burning Rock Biotech (BNR) EBT Margin (2019 - 2026)
Burning Rock Biotech (BNR) posted quarterly EBT Margin of 15.96% for Q1 2026, down 598.0% year-over-year from 3.21% in Q1 2025, and down 39.02% quarter-over-quarter from 11.48% in Q4 2025.
Burning Rock Biotech (BNR) EBT Margin (2019 - 2026) Analysis & Trends
Burning Rock Biotech's EBT Margin history runs 8 years deep, the most recent figure standing at 15.96% for Q1 2026.
- In Q1 2026, EBT Margin fell 598.0% year-over-year to 15.96%; the TTM figure through Mar 2026 stood at 11.27% (up 3302.0% YoY), while the FY2025 annual figure was 9.97%, up 5609.0% from the prior year.
- EBT Margin for Q1 2026 stood at 15.96%, down from 11.48% in the prior quarter.
- The five-year high for EBT Margin was 6.37% in Q2 2025, with the low at 200.29% in Q2 2022.
- The 5-year median for EBT Margin is 89.42% (2023), against an average of 88.41%.
- The sharpest annual moves came in 2022 and 2023: EBT Margin slumped 4155 bps in 2022, then soared 11087 bps in 2023.
- Burning Rock Biotech's EBT Margin stood at 150.68% in 2022, then gained by 12 bps to 133.09% in 2023, then jumped by 55 bps to 60.29% in 2024, then jumped by 81 bps to 11.48% in 2025, then slumped by 39 bps to 15.96% in 2026.
- Business Quant data shows BNR's EBT Margin at 15.96% in Q1 2026, 11.48% in Q4 2025, and 12.58% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 16.04% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 17.21% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 34.29% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 22.23% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 6.89% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -12.17% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 22.43% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 28.17% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 13.54% |
| 10 | Burning Rock Biotech | 781.17 Mn | 711.04 Mn | 11.31 Mn | -15.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.96% |
| Dec 31, 2025 | -11.48% |
| Sep 30, 2025 | -12.58% |
| Jun 30, 2025 | -6.37% |
| Mar 31, 2025 | -9.98% |
| Dec 31, 2024 | -60.29% |
| Sep 30, 2024 | -27.64% |
| Jun 30, 2024 | -79.57% |
| Mar 31, 2024 | -96.61% |
| Dec 31, 2023 | -133.09% |
| Sep 30, 2023 | -136.80% |
| Jun 30, 2023 | -89.42% |
| Mar 31, 2023 | -129.69% |
| Dec 31, 2022 | -150.68% |
| Sep 30, 2022 | -149.70% |
| Jun 30, 2022 | -200.29% |
| Mar 31, 2022 | -192.87% |
| Dec 31, 2021 | -171.22% |
| Sep 30, 2021 | -134.31% |
| Jun 30, 2021 | -158.74% |